2019 publications (13)
Tet inactivation disrupts YY1 binding and long-range chromatin interactions to cause developmental defects in embryonic heart.
Fang S, Li J, Xiao Y, Lee M, Guo L, Han W, Li T, Hill MC, Mo W, Xu R, Wang F, Chang J, Zhou Y, Sun D, Martin JF, and Huang Y.
Nature Communications. 2019,10(1):4297. First report of cardiomyopathy associated with TET deficiency.
Single-atom fluorescence switch: a general approach towards visible light-activated dyes for biological imaging.
Tang J, Robichaux M, Wu KL, Pei J, Nguyen NT, Zhou Y, Wensel TG, and Xiao H.
Journal of the American Chemical Society. 2019,141(37):14699-706. TMC News.
Myeloid loss of Beclin 1 promotes PD-L1hi precursor B cell lymphoma development. Tan P, He L, Xing C, Mao J, Yu X, Zhu M, Diao L, Han L, Zhou Y, You JM, Wang HY, and Wang RF. Journal of Clinical Investigation. 2019,129(12): 5261-77. Discovery of small molecule inhibitors of the HSP90-Calcineurin-NFAT pathway against glioblastoma. Liu Z, Li H, He L, Yu X, Tian C, Tan P, Li C, Jing J, Tian Y, Du L, Huang Y, Han L, Li M, and Zhou Y#. Cell Chemical Biology. 2019,26(3):352-65. *Highlighted as a Cover article; Vital Record: "A new way to stop brain cancer"; *The Battalion: "Research team discovers new compounds that could treat glioblastoma" Antibiotic treatment ameliorates Ten-eleven translocation 2 (TET2) loss-of-function associated hematological malignancies. Zeng H, He L, Guo L, Li J, Lee M, Han W, Guzman AG, Zang S, Zhou Y, Zhang X, Goodell MA, King KY, Sun D, and Huang Y. Cancer Letters. 2019,467:1-8.
Comprehensive characterization of circular RNAs in ~ 1000 human cancer cell lines. Ruan H, Xiang Y, Ko J, Li S, Jing Y, Zhu X, Ye Y, Zhang Z, Mills T, Feng J, Liu CJ, Jing J, Cao J, Zhou B, Wang L, Zhou Y, Lin C, Guo AY, Chen X, Diao L, Li W, Chen Z, He X, Mills GB, Blackburn MR, and Han L. Genome Medicine. 2019,11(1):55.
Tmem178 negatively regulates store-operated calcium entry in myeloid cells via association with STIM1. Yang Z, Yan H, Dai W, Jing J, Yang Y, Mahajan S, Zhou Y, Li W, Macaubas C, Mellins ED, Shih CC, Fitzpatrick J, and Faccio R. Journal of Autoimmunity. 2019,101:94-108.
Discovery of turn-on fluorescent probes for detecting Bcl-2 protein. Liu T, Dong G, Xu F, Han B, Fang H, Huang Y, Zhou Y, Du L and Li M. Analytical Chemistry. 2019,9(19):5722-8. Highlighted as a Cover Article
STIM2 interacts with AMPK and regulates calcium-induced AMPK activation. Chauhan AS, Liu X, Jing J, Lee H, Yadav RK, Liu J, Zhou Y, and Gan B. FASEB Journal. 2019,33(2):2957-70.
p53-dependent autophagic degradation of TET2 modulates cancer therapeutic resistance. Zhang J, Tan P, Guo L, Gong J, Ma J, Li J, Lee M, Fang S, Jing J, Johnson G, Sun D, Cao WM, Dashwood R, Han L, Dong WG, Zhou Y#, Wei-Guo Dong#, and Huang Y#. Oncogene. 2019,38(11):1905-19. Near-infrared-light activatable nanoparticles for deep-tissue-penetrating wireless optogenetics. Yu N, Huang L, Zhou Y#, Xue T#, Chen Z#, Han G#. Advanced Healthcare Materials. 2019:e1801132. *Top downloaded paper 2018-2019
TRIM59 deficiency curtails breast cancer metastasis through SQSTM1-selective autophagic degradation of PDCD10. Tan P, He L and Zhou Y#. Autophagy. 2019,15(4):747-9. Autophagy and viral infection. Mao J, Lin E, He L, Yu J, Tan P and Zhou Y#. Advances in Experimental Medicine and Biology. 2019,1209:55-78.
Myeloid loss of Beclin 1 promotes PD-L1hi precursor B cell lymphoma development. Tan P, He L, Xing C, Mao J, Yu X, Zhu M, Diao L, Han L, Zhou Y, You JM, Wang HY, and Wang RF. Journal of Clinical Investigation. 2019,129(12): 5261-77. Discovery of small molecule inhibitors of the HSP90-Calcineurin-NFAT pathway against glioblastoma. Liu Z, Li H, He L, Yu X, Tian C, Tan P, Li C, Jing J, Tian Y, Du L, Huang Y, Han L, Li M, and Zhou Y#. Cell Chemical Biology. 2019,26(3):352-65. *Highlighted as a Cover article; Vital Record: "A new way to stop brain cancer"; *The Battalion: "Research team discovers new compounds that could treat glioblastoma" Antibiotic treatment ameliorates Ten-eleven translocation 2 (TET2) loss-of-function associated hematological malignancies. Zeng H, He L, Guo L, Li J, Lee M, Han W, Guzman AG, Zang S, Zhou Y, Zhang X, Goodell MA, King KY, Sun D, and Huang Y. Cancer Letters. 2019,467:1-8.
Comprehensive characterization of circular RNAs in ~ 1000 human cancer cell lines. Ruan H, Xiang Y, Ko J, Li S, Jing Y, Zhu X, Ye Y, Zhang Z, Mills T, Feng J, Liu CJ, Jing J, Cao J, Zhou B, Wang L, Zhou Y, Lin C, Guo AY, Chen X, Diao L, Li W, Chen Z, He X, Mills GB, Blackburn MR, and Han L. Genome Medicine. 2019,11(1):55.
Tmem178 negatively regulates store-operated calcium entry in myeloid cells via association with STIM1. Yang Z, Yan H, Dai W, Jing J, Yang Y, Mahajan S, Zhou Y, Li W, Macaubas C, Mellins ED, Shih CC, Fitzpatrick J, and Faccio R. Journal of Autoimmunity. 2019,101:94-108.
Discovery of turn-on fluorescent probes for detecting Bcl-2 protein. Liu T, Dong G, Xu F, Han B, Fang H, Huang Y, Zhou Y, Du L and Li M. Analytical Chemistry. 2019,9(19):5722-8. Highlighted as a Cover Article
STIM2 interacts with AMPK and regulates calcium-induced AMPK activation. Chauhan AS, Liu X, Jing J, Lee H, Yadav RK, Liu J, Zhou Y, and Gan B. FASEB Journal. 2019,33(2):2957-70.
p53-dependent autophagic degradation of TET2 modulates cancer therapeutic resistance. Zhang J, Tan P, Guo L, Gong J, Ma J, Li J, Lee M, Fang S, Jing J, Johnson G, Sun D, Cao WM, Dashwood R, Han L, Dong WG, Zhou Y#, Wei-Guo Dong#, and Huang Y#. Oncogene. 2019,38(11):1905-19. Near-infrared-light activatable nanoparticles for deep-tissue-penetrating wireless optogenetics. Yu N, Huang L, Zhou Y#, Xue T#, Chen Z#, Han G#. Advanced Healthcare Materials. 2019:e1801132. *Top downloaded paper 2018-2019
TRIM59 deficiency curtails breast cancer metastasis through SQSTM1-selective autophagic degradation of PDCD10. Tan P, He L and Zhou Y#. Autophagy. 2019,15(4):747-9. Autophagy and viral infection. Mao J, Lin E, He L, Yu J, Tan P and Zhou Y#. Advances in Experimental Medicine and Biology. 2019,1209:55-78.